Arrowhead Pharmaceuticals, Inc. (ARWR)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 14, 2025

$19.95

P/E Ratio

N/A

Market Cap

$2.52B

Description
Add to research

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Metrics
Add to research

Overview

  • HQPasadena, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerARWR
  • Price$19.95+4.40%

Trading Information

  • Market cap$2.52B
  • Float93.07%
  • Average Daily Volume (1m)2,602,946
  • Average Daily Volume (3m)2,062,578
  • EPS-$5.15

Company

  • Revenue$2.50M
  • Rev growth (1yr)-29.60%
  • Net income-$173.08M
  • Gross margin-109.40%
  • EBITDA margin-6,247.08%
  • EBITDA-$156.18M
  • EV$2.67B
  • EV/Revenue1,067.90
  • P/EN/A
  • P/S996.29
  • P/B47.64
  • Debt/Equity1,658.23
Documents
Add to research